Skip to main content
Premium Trial:

Request an Annual Quote

Capitainer, Life Genomics Partner on Self-Sampling Diagnostics

NEW YORK – Swedish sample collection firm Capitainer announced Wednesday that it has entered into a strategic partnership with Swedish laboratory Life Genomics to offer self-sampling diagnostic tests. 

The collaboration will extend the reach of Capitainer's self-sampling technology to new audiences and will allow Life Genomics to broaden its range and offer home-based testing options, Capitainer said in a statement. It also provides opportunities for Capitainer to widely introduce new services that use its self-sampling solutions, the company added. 

The first new test that will be offered under the partnership is an assay for hypothyroidism, which is detected using the markers TSH and FT4. 

"It's highly encouraging to see a Swedish lab advancing home testing while ensuring the quality of analysis remains high for those requiring TSH and FT4 measurements," Capitainer Chief Medical Officer Mathias Karlsson said in a statement. "This development paves the way for numerous possibilities to simplify the process for individuals and to discover efficient, sustainable healthcare practices." 

Capitainer's self-sampling technology allows patients to use a card to collect samples of blood, plasma, or urine that can then be sent through standard mail without requiring refrigeration or special packaging. 

In an email, Capitainer CEO Christopher Aulin said that the firms would also explore the potential of applying Capitainer's sampling technology to molecular diagnostics, but the first goal is to focus on more common biomarkers.

Gothenburg, Sweden-based Life Genomics offers genetic testing services, including noninvasive prenatal testing and endometriosis testing, to healthcare professionals and the public. 

The collaboration "represents a natural evolution of our offerings, where we see the opportunity to apply our profound knowledge and our well-established laboratory to new types of tests," Life Genomics CEO Göran Jacobsson said.